Intelligent Bio Reports 38% Revenue Growth, 48.6% Gross Margin
Intelligent Bio Solutions Inc. reported fiscal 2026 revenue of $4.2 million, up 38% year-over-year, driven by a growing reader installed base and high-margin cartridge sales. Gross profit margin expanded 778 basis points to 48.63%.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day